| CD44 is a key player in non-alcoholic steatohepatitis S Patouraux, D Rousseau, S Bonnafous, C Lebeaupin, C Luci, ... Journal of hepatology 67 (2), 328-338, 2017 | 115 | 2017 |
| Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events J Boursier, H Hagström, M Ekstedt, C Moreau, M Bonacci, S Cure, ... Journal of Hepatology 76 (5), 1013-1020, 2022 | 87 | 2022 |
| Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH J Boursier, R Anty, L Vonghia, V Moal, T Vanwolleghem, CM Canivet, ... Alimentary pharmacology & therapeutics 47 (10), 1387-1396, 2018 | 69 | 2018 |
| Impact of type 2 diabetes on the accuracy of noninvasive tests of liver fibrosis with resulting clinical implications J Boursier, CM Canivet, C Costentin, A Lannes, A Delamarre, N Sturm, ... Clinical Gastroenterology and Hepatology 21 (5), 1243-1251. e12, 2023 | 45 | 2023 |
| Transient Versus Two‐Dimensional Shear‐Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD C Cassinotto, J Boursier, A Paisant, B Guiu, M Irles‐Depe, C Canivet, ... Hepatology 73 (6), 2196-2205, 2021 | 37 | 2021 |
| The differential expression of cide family members is associated with nafld progression from steatosis to steatohepatitis A Sans, S Bonnafous, D Rousseau, S Patouraux, CM Canivet, PS Leclere, ... Scientific reports 9 (1), 7501, 2019 | 35 | 2019 |
| Severe vitamin D deficiency may be an additional cofactor for the occurrence of alcoholic steatohepatitis R Anty, CM Canivet, S Patouraux, P Ferrari‐Panaia, MC Saint‐Paul, ... Alcoholism: Clinical and Experimental Research 39 (6), 1027-1033, 2015 | 32 | 2015 |
| Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver CM Canivet, S Bonnafous, D Rousseau, PS Leclere, S Lacas-Gervais, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (5), 165705, 2020 | 31 | 2020 |
| Severe vitamin D deficiency is not associated with liver damage in morbidly obese patients R Anty, A Hastier, CM Canivet, S Patouraux, AS Schneck, ... Obesity surgery 26, 2138-2143, 2016 | 30 | 2016 |
| Immunoglobulin G4-associated autoimmune hepatitis may be found in Western countries CM Canivet, R Anty, S Patouraux, MC Saint-Paul, C Lebeaupin, P Gual, ... Digestive and Liver Disease 48 (3), 302-308, 2016 | 25 | 2016 |
| Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD CM Canivet, C Costentin, KM Irvine, A Delamarre, A Lannes, N Sturm, ... Hepatology 77 (3), 920-930, 2023 | 23 | 2023 |
| Anti-diabetic drugs and NASH: from current options to promising perspectives S Smati, CM Canivet, J Boursier, B Cariou Expert opinion on investigational drugs 30 (8), 813-825, 2021 | 21 | 2021 |
| The periscreen strip is highly efficient for the exclusion of spontaneous bacterial peritonitis in cirrhotic outpatients T Thévenot, C Briot, V Macé, H Lison, L Elkrief, A Heurgué-Berlot, ... Official journal of the American College of Gastroenterology| ACG 111 (10 …, 2016 | 19 | 2016 |
| Determinants associated with the correction of glomerular hyper-filtration one year after bariatric surgery G Favre, R Anty, C Canivet, G Clément, I Ben-Amor, A Tran, J Gugenheim, ... Surgery for Obesity and Related Diseases 13 (10), 1760-1766, 2017 | 17 | 2017 |
| The mid-infrared spectroscopy: A novel non-invasive diagnostic tool for NASH diagnosis in severe obesity R Anty, M Morvan, M Le Corvec, CM Canivet, S Patouraux, J Gugenheim, ... JHEP Reports 1 (5), 361-368, 2019 | 14 | 2019 |
| Reliability criteria of two-dimensional shear wave elastography: analysis of 4277 measurements in 788 patients A Paisant, S Lemoine, C Cassinotto, V de Lédinghen, M Ronot, ... Clinical Gastroenterology and Hepatology 20 (2), 400-408. e10, 2022 | 12 | 2022 |
| Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study R Anty, G Favre, A Coilly, E Rossignol, P Houssel‐Debry, C Duvoux, ... Alimentary Pharmacology & Therapeutics 47 (12), 1682-1689, 2018 | 11 | 2018 |
| Screening for liver fibrosis in the general population: where do we stand in 2022? CM Canivet, J Boursier Diagnostics 13 (1), 91, 2022 | 9 | 2022 |
| Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners CM Canivet, S Smati, A Lannes, J Brisseau, L Judon, M Le Roch, ... Clinics and research in hepatology and gastroenterology 46 (4), 101848, 2022 | 8 | 2022 |
| No association between binge eating disorder and severity of non‐alcoholic fatty liver disease in severely obese patients CM Canivet, P Perney, F Cherick, M Orlowski, S Patouraux, ... JGH Open 4 (3), 525-531, 2020 | 8 | 2020 |
